Yahoo
Shenzhen - Delayed Quote CNY

China National Accord Medicines Corporation Ltd. (000028.SZ)

21.66 +0.26 (+1.21%)
At close: 3:04:18 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
73,357,457.99
73,415,858.42
74,378,494.39
75,477,484.62
73,443,136.99
Cost of Revenue
65,729,994.68
65,575,391.36
66,129,208.57
66,425,425.56
64,516,926.01
Gross Profit
7,627,463.32
7,840,467.07
8,249,285.82
9,052,059.06
8,926,210.98
Operating Expense
5,800,719.47
5,994,545.78
6,575,515.98
6,552,699.07
6,513,741.20
Operating Income
1,826,743.85
1,845,921.29
1,673,769.84
2,499,359.99
2,412,469.78
Net Non Operating Interest Income Expense
-162,173.59
-184,334.97
-237,574.39
-207,489.33
-189,077.21
Pretax Income
1,508,355.38
1,509,020.33
575,469.44
2,473,226.54
2,311,070.12
Tax Provision
383,453.81
380,671.65
338,465.91
514,739.44
539,332.13
Net Income Common Stockholders
1,131,298.40
1,135,926.83
642,493.45
1,599,255.76
1,486,707.65
Basic EPS
1.85
1.85
1.05
2.61
2.43
Diluted EPS
1.85
1.85
1.05
2.61
2.43
Basic Average Shares
610,284.36
612,509.57
614,558.95
612,955.17
612,501.28
Diluted Average Shares
610,284.36
612,509.57
614,558.95
612,955.17
612,501.28
Total Operating Income as Reported
1,506,539.49
1,512,828.83
573,478.28
2,467,425.16
2,306,068.62
Rent Expense Supplemental
16,258.69
19,051.59
14,144.41
20,008.62
24,785.35
Total Expenses
71,530,714.15
71,569,937.14
72,704,724.55
72,978,124.63
71,030,667.21
Net Income from Continuing & Discontinued Operation
1,131,298.40
1,135,926.83
642,493.45
1,599,255.76
1,486,707.65
Normalized Income
1,411,156.25
1,444,506.02
1,540,148.63
1,688,378.71
1,651,851.17
Interest Income
32,905.12
46,952.87
58,523.38
77,554.16
72,935.65
Interest Expense
160,429.98
194,497.66
258,301.91
248,381.40
261,908.26
Net Interest Income
-162,173.59
-184,334.97
-237,574.39
-207,489.33
-189,077.21
EBIT
1,668,785.36
1,703,517.99
833,771.34
2,721,607.95
2,572,978.38
EBITDA
1,668,785.36
3,061,828.36
2,492,043.46
4,147,262.72
3,880,404.22
Reconciled Cost of Revenue
65,729,994.68
65,575,391.36
66,129,208.57
66,425,425.56
64,516,926.01
Reconciled Depreciation
1,500,172.67
1,261,180.79
1,545,349.66
1,425,654.77
1,307,425.84
Net Income from Continuing Operation Net Minority Interest
1,131,298.40
1,135,926.83
642,493.45
1,599,255.76
1,486,707.65
Total Unusual Items Excluding Goodwill
-375,255.13
-412,684.72
-1,196,873.57
-112,546.69
-215,414.61
Total Unusual Items
-375,255.13
-412,684.72
-1,196,873.57
-112,546.69
-215,414.61
Normalized EBITDA
2,044,040.49
3,474,513.08
3,688,917.03
4,259,809.41
4,095,818.83
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-95,397.29
-104,105.54
-299,218.39
-23,423.74
-50,271.09
12/31/2022 - 6/8/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: